Published in BMC Cancer on January 23, 2015
RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis. Oncotarget (2016) 0.75
Targeting histone methylation for colorectal cancer. Therap Adv Gastroenterol (2016) 0.75
DUSP1 promoter methylation in peripheral blood leukocyte is associated with triple-negative breast cancer risk. Sci Rep (2017) 0.75
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Comprehensive molecular characterization of human colon and rectal cancer. Nature (2012) 34.13
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov (2012) 26.98
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet (2006) 13.63
CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A (1999) 13.02
Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res (1997) 8.88
Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res (2005) 6.49
Recurrent R-spondin fusions in colon cancer. Nature (2012) 5.10
Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology (2010) 4.25
Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res (1999) 3.48
High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology (2006) 3.24
Interplay between the cancer genome and epigenome. Cell (2013) 3.05
Long noncoding RNAs and the genetics of cancer. Br J Cancer (2013) 2.98
The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression. J Biol Chem (1998) 1.67
Promoter methylation-mediated downregulation of PRDM5 contributes to the development of lung squamous cell carcinoma. Tumour Biol (2014) 1.50
Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. Cancer Res (2013) 1.42
Oncogenic PIK3CA mutations in colorectal cancers and polyps. Int J Cancer (2011) 1.40
KRAS variation and risk of endometriosis. Mol Hum Reprod (2006) 1.33
Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability. Oncogene (2006) 1.32
Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas. Int J Cancer (2004) 1.28
PRDM5 is silenced in human cancers and has growth suppressive activities. Oncogene (2004) 1.24
PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer. Clin Cancer Res (2007) 1.21
Epigenetic regulation of protein-coding and microRNA genes by the Gfi1-interacting tumor suppressor PRDM5. Mol Cell Biol (2007) 1.19
Mutations in PRDM5 in brittle cornea syndrome identify a pathway regulating extracellular matrix development and maintenance. Am J Hum Genet (2011) 1.15
Prdm5 regulates collagen gene transcription by association with RNA polymerase II in developing bone. PLoS Genet (2012) 1.09
Intermediate methylation epigenotype and its correlation to KRAS mutation in conventional colorectal adenoma. Am J Pathol (2011) 1.07
Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients. Carcinogenesis (2011) 1.07
The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/β-catenin signaling and is frequently silenced in multiple tumors. PLoS One (2011) 1.05
The tumor suppressor PRDM5 regulates Wnt signaling at early stages of zebrafish development. PLoS One (2009) 0.98
Molecular karyotype (amplotype) of metastatic colorectal cancer by unbiased arbitrarily primed PCR DNA fingerprinting. Proc Natl Acad Sci U S A (1998) 0.96
A clinicopathological and molecular analysis of 200 traditional serrated adenomas. Mod Pathol (2014) 0.93
Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancers. PLoS One (2012) 0.93
CpG island methylation is frequently present in tubulovillous and villous adenomas and correlates with size, site, and villous component. Hum Pathol (2007) 0.92
Tracking recurrent quantitative genomic alterations in colorectal cancer: allelic losses in chromosome 4 correlate with tumor aggressiveness. Lab Invest (1999) 0.90
Prdm5 suppresses Apc(Min)-driven intestinal adenomas and regulates monoacylglycerol lipase expression. Oncogene (2013) 0.89
p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers. Int J Cancer (2011) 0.88
Characteristics of advanced- and non advanced sporadic polypoid colorectal adenomas: correlation to KRAS mutations. Pathol Oncol Res (2012) 0.86
The CIMP Phenotype in BRAF Mutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort. Gastroenterol Res Pract (2014) 0.84
DNA methylation and carcinogenesis of PRDM5 in cervical cancer. J Cancer Res Clin Oncol (2010) 0.81
Microsatellite stable colorectal cancers stratified by the BRAF V600E mutation show distinct patterns of chromosomal instability. PLoS One (2014) 0.80